Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

BackgroundNeonates are more susceptible to acute respiratory failure than older children. It is unknown to what extent high-flow nasal cannula (HFNC) alters intrathoracic pressure (ITP), potentially decreasing cardiac output (CO) due to cardiopulmonary interactions. This study evaluated the impact of flow titration on tracheal pressure (a surrogate for ITP) and CO via HFNC in an established porcine model of neonatal respiratory failure. Unlike prior research, this study examines both ITP and CO demonstrating that although the ITP increased with higher HFNC flows, CO did not decrease.MethodsTwenty-three neonatal Landrace-Yorkshire pigs (2-4 kg) were anesthetized, and monitoring lines were placed. Baseline vital signs, CO, mean intratracheal pressure (Ptr), and PaO were measured. CO was assessed via computerized COstatus cardiac system. Lung injury was induced using oleic acid (0.08 mL/kg), resulting in ≤50% reduction in preinjury PaO on 1 L/min oxygen. After injury, in random order, pigs received HFNC flows of 1, 2, and 3 L/kg/min at 100% FiO for 30 min each. Measurements were repeated, and data were analyzed via mixed-effects repeated measures ANOVA.ResultsAfter OA injury, PaO significantly decreased (414 to 125 mmHg; < 0.001). Mean Ptr and PaO increased significantly ( < .001) with increasing HFNC flow rates. CO showed no significant changes; thus, no correlation between CO with Ptr and/or HFNC flow levels was demonstrated.ConclusionsIn neonatal respiratory distress, higher HFNC flows improved oxygenation without negatively impacting CO in this neonatal porcine lung injury model, despite increasing intra-thoracic pressure (1-3 L/min/kg).

Download full-text PDF

Source
http://dx.doi.org/10.1177/19345798251363449DOI Listing

Publication Analysis

Top Keywords

hfnc flows
12
cardiac output
8
high-flow nasal
8
nasal cannula
8
neonatal porcine
8
porcine model
8
respiratory failure
8
neonatal respiratory
8
higher hfnc
8
ptr pao
8

Similar Publications

Comparing High-Flow Nasal Cannula and Non-Invasive Ventilation in Critical Care: Insights from Deep Counterfactual Inference.

Res Sq

August 2025

Department of Biomedical Informatics (Xiaolei Lu, Jonathan Y. Lam, Aaron E. Boussina, and Shamim Nemati), the Division of Pulmonary, Critical Care, and Sleep Medicine (Michael Miller, Alex K. Pearce, Atul Malhotra), University of California, San Diego, La Jolla, CA; Department of Informatics (Kai Zh

Randomized trials comparing high-flow nasal cannula (HFNC) and non-invasive positive pressure ventilation (NIV) for acute respiratory failure (ARF) offer population-level guidance but often fail to capture individual variability in treatment response. In this retrospective study, we identified intensive care units (ICU) patients at risk of invasive mechanical ventilation (IMV) using a previously published risk prediction model. Patients who first received HFNC or NIV after crossing the high-risk threshold formed the early treatment cohort.

View Article and Find Full Text PDF

BackgroundNeonates are more susceptible to acute respiratory failure than older children. It is unknown to what extent high-flow nasal cannula (HFNC) alters intrathoracic pressure (ITP), potentially decreasing cardiac output (CO) due to cardiopulmonary interactions. This study evaluated the impact of flow titration on tracheal pressure (a surrogate for ITP) and CO via HFNC in an established porcine model of neonatal respiratory failure.

View Article and Find Full Text PDF

Aerosol Delivery to an Adult Model via High-Flow Nasal Cannula with Inspiration-Synchronized Small-Particle Vibrating Mesh Nebulizer.

J Aerosol Med Pulm Drug Deliv

July 2025

Department of Cardiopulmonary Sciences, Division of Respiratory Care, Rush University, Chicago, Illinois, USA.

Aerosol delivery via high-flow nasal cannula (HFNC) with an inspiration-synchronized vibrating mesh nebulizer (VMN) yielded higher inhaled doses than with a continuous VMN. Recently, a prototype VMN generating aerosol particles <3 µm improved aerosol delivery during invasive ventilation in adult and pediatric models, outperforming the conventional VMN. However, the effects of inspiration-synchronized small-particle VMN during HFNC remain unknown.

View Article and Find Full Text PDF

Impact of Weight-Based High-Flow Nasal Cannula Flow Limits on Intensive Care Unit Utilization in Bronchiolitis.

Respir Care

May 2025

Drs. Hasan and Volk are affiliated with Division of Pediatric Critical Care Medicine, Department of Pediatrics, UT Southwestern Medical Center, Dallas, Texas, USA.

High-flow nasal cannula (HFNC) is a common respiratory support device utilized in the management of children hospitalized with bronchiolitis. Early adoption in many pediatric wards was developed using age-based flow limits. However, age-based limits do not align with current evidence and potentially contribute to ICU admissions.

View Article and Find Full Text PDF

Impact of High-Flow Nasal Cannula Oxygen Therapy on the Pressure of the Airway System in Humans.

Respir Care

January 2025

Mrs. Moracci and Plotnikow are affiliated with the Physical and Respiratory Therapy Department, Intensive Care Unit, Hospital Británico de Buenos Aires, Ciudad Autónoma de Buenos Aires, Argentina.

The understanding of how pharyngeal pressure is transmitted to the trachea with high-flow nasal cannula (HFNC) implementation and the behavior of tracheal pressure in the presence of mouth leaks remains controversial. This study aimed to assess the impact of HFNC administration on tracheal pressure by comparing measurements taken with open and closed mouth with varying flows. A crossover study was conducted between March 2019 and June 2023.

View Article and Find Full Text PDF